Tarek Mekhail, M.D.
| Appointed: |
2002 |
| Gender: |
Male |
| Languages: |
Arabic
English |
Solid Tumor Oncology
Hematologic Oncology and Blood Disorders
Biographical Sketch
Tarek Mekhail, MD, is a Staff Physician in the Solid Tumor Oncology Department at Cleveland Clinic’s main campus. He was appointed in 2002, subsequent to serving as Hematology and Medical Oncology Fellow at Cleveland Clinic. He also serves as Director of the Lung Cancer Medical Oncology Program at Cleveland Clinic’s Taussig Cancer Center.
Dr. Mekhail is board-certified in hematology, medical oncology and internal medicine. His special interests include lung cancer, head and neck cancer, kidney cancer, aerodigestive malignancies and the development of novel agents.
Dr. Mekhail received his medical degree from the Faculty of Medicine, Cairo University, Egypt, in 1984. He earned fellowships in ENT and head and neck surgery from the Royal College of Surgeons in Ireland and the Royal College of Surgeons of Edinburgh, United Kingdom.
He has authored and co-authored more than 100 peer-reviewed articles, abstracts for medical journals and book chapters related to his field. He has also delivered numerous oncology presentations in the United States, Canada and Germany. Dr. Mekhail is a member of the American Society of Clinical Oncology and the American Association of Cancer Research, among others. He was awarded the Teacher of the Year Award in the Hematology/Medical Oncology Program in 2004 and 2005.
Education & Fellowships
| Medical School: | Cairo University Faculty of Medicine, Cairo, Egypt |
|
| Internship: | Cleveland Clinic, Internal Medicine, Cleveland, OH |
| Residency: | Cleveland Clinic, Internal Medicine, Cleveland, OH |
| Fellowship: | Cleveland Clinic, Hematology & Medical Oncology, Cleveland, OH |
| Fellowship: | Royal College of Surgeons in Edinburgh, ENT & Head and Neck Surgery, United Kingdom |
| Fellowship: | Royal College of Surgeons Ireland, ENT & Head and Neck Surgery, Dublin, Ireland |
| Other Education: | (Graduate) Cairo University Faculty of Medicine, Cairo, Egypt |
Certifications
Hematology
Medical Oncology
Internal Medicine
Specialty Interests
Lung cancer, head and neck cancer, kidney cancer, development of novel agents.
Awards & Honors
Teacher of the Year Award, Hematology/Medical Oncology Program, Cleveland Clinic, 2004, 2005
Professional Memberships
- American Society of Clinical Oncology
- South West Oncology Group
- American Association of Cancer Research
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Mekhail has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Mekhail receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Eli Lilly and Company
- Genentech, Inc.
- Sanofi-Aventis US Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
